Human immunodeficiency virus 1 strains resistant to nucleoside inhibitors of reverse transcriptase in isolates from the Czech Republic as monitored by line probe assay and nucleotide sequencing

Acta Virologica

Volumn 45, Issue 5-6, 2001, Pages 279-286

  Reinis M ^a   Vandasova J ^a   Stankova M ^a   Linka, M ^a   Bruckova M ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

Antiviral drugs; Human immunodeficiency virus 1; Line probe assay; Nucleotide sequencing; Resistant mutants; Reverse transcriptase

Indexed keywords

DIDANOSINE; LAMIVUDINE; MUTANT PROTEIN; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CONTROLLED STUDY; CZECH REPUBLIC; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LINE PROBE ASSAY; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PHYLOGENETIC TREE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS ISOLATION; VIRUS LOAD; VIRUS STRAIN; ANTIBIOTIC RESISTANCE; CODON; COMPARATIVE STUDY; DNA SEQUENCE; DRUG ANTAGONISM; DRUG EFFECT; GENETIC PROCEDURES; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; MUTATION; PHYLOGENY; PREVALENCE;

BASE SEQUENCE; CODON; COMPARATIVE STUDY; CZECH REPUBLIC; DIDANOSINE; DRUG RESISTANCE, VIRAL; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMAN; LAMIVUDINE; MOLECULAR PROBE TECHNIQUES; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; PREVALENCE; REVERSE TRANSCRIPTASE INHIBITORS; SEQUENCE ANALYSIS, DNA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; ZALCITABINE; ZIDOVUDINE; HUMANS;

EID: 0035527520     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy
2. Line probe assay for detection of Human Immunodeficiency Virus Type 1 mutations conferring resistance to nucleoside inhibitors of reverse transcriptase: Comparison with sequence analysis
3. Drug-resistance genotyping in HIV-1 therapy: The VIRADAPT randomised controlled trial
4. Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: Recommendations for European setting
5. Mutations in retroviral genes associated with drug resistance
6. Genetic polymorphism near HIV-1 reverse transcriptase resistance-associated codons is a major obstacle for the line probe assay as an alternative method to sequence analysis
7. HIV-1 diversity in heterosexual population in Slovakia, Ukraine and the Czech Republic
8. Lamivudine-resistant human immunodeficiency virus type 1 variants (184V) require multiple amino acid changes to become co-resistant to zidovudine in vivo
9. Comparison of Line Probe Assay (LIPA) and sequence analysis for detection of HIV-1 drug resistance
10. Molecular epidemiology of HIV type 1 isolates from the Czech Republic: Identification of an env E subtype case
11. Genetic subtypes of HIV type 1 viruses circulating in the Czech Republic
12. Comparison of the lip HIV-1 RT test, selective PCR and direct solid phase sequencing for the detection of HIV-1 drug resistance mutations
13. Human immunodeficiency virus reverse transcriptase and protease sequence database
14. Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase
15. Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene
16. TREECON for Windows: A software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment
17. Comparative evaluation of three human immunodeficiency virus genotyping systems: The HIV-GenotypR method, the HIVPRT GeneChip assay, and the HIV-1 RT line probe assay